Treatment of autosomal recessive hearing loss via in vivo CRISPR/Cas9-mediated optimized homology-directed repair in mice

Cell Res. 2022 Jul;32(7):699-702. doi: 10.1038/s41422-022-00624-y. Epub 2022 Feb 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CRISPR-Associated Protein 9 / metabolism
  • CRISPR-Cas Systems* / genetics
  • Gene Editing
  • Hearing Loss* / genetics
  • Hearing Loss* / therapy
  • Mice

Substances

  • CRISPR-Associated Protein 9